Emerging biotech platforms and clinical-phase pipelines offering localized immunotherapy, gene delivery, and tumor microenvironment modulation are driving growth in intratumoral cancer therapies globally. https://www.datamintelligence.com/research-report/intratumoral-cancer-therapies-market